This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Harvard College wins reprieve following Indian Patent Office's 'glaring error'

By Freny Patel ( April 3, 2026, 00:27 GMT | Insight) -- Harvard College’s insulin-cell patent rejection was overturned by an Indian court, which cited a "glaring error" by the Controller General of Patents, Designs, and Trademarks. The Delhi High Court ordered a fresh review of the university’s engineered, non-native cells.The president and fellows of Harvard College have won a reprieve in India after the Delhi High Court set aside a patent rejection and ordered a fresh review of their application for lab-engineered pancreatic cells....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login